Moreover, since a recent study reported that anti-estrogen therapy sensitizes estrogen receptor-positive (ER+) breast cancer to ferroptosis (Liang et al, 2023), we explored whether endocrine therapy could induce ferroptosis by a mechanism involving FADS1/2 axis. The gene discussed is FADS1; the disease is breast carcinoma.